Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business
In part 2 of our Q&A, Okamura addresses the need for biopharma companies to leverage digital technologies in disease management.
Diabetes care needs to support lifestyle changes – not pharmaceutical intervention – first
While pharmaceuticals are a critical piece of the treatment landscape for type 2 diabetes, they have been the exclusive and de-facto first-line treatment for too long. Prescription digital therapeutics can and should be considered as part of type 2 diabetes therapies.
The Human Algorithm: What AI Can’t Replace in Pharma Engagement
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.
FDA clears first VR-based tool for for lower-back pain
The Food and Drug Administration granted the company de novo clearance for its VR programs to help reduce chronic lower back pain. AppliedVR’s eight-week program is based on cognitive behavioral therapy.